%0 Journal Article
%T Research Progress of Targeted Therapy for EGFR Gene in Non-small Cell Lung Cancer
%A Hui ZHANG
%A Shucai ZHANG
%J Öйú·Î°©ÔÓÖ¾
%D 2017
%R : 10.3779/j.issn.1009-3419.2017.01.09
%X Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have brought great clinical benefit to patients with EGFR-sensitive mutations. With the deepening of clinical and basic research, EGFR-TKIs have received more and more attention. In this review, we summarize the latest research development about EGFR-targeted drugs in 2016.
%K Lung neoplasms
%K Epidermal growth factor receptor
%K Mutation
%K Targeted therapy
%U http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2017.01.09